The retail pharmacy will stock Auvi-Q, an epinephrine auto-injector manufactured by Kaleo, which was previously only available through its mail delivery program.
The list price for Auvi-Q is steep at $4,500; however, a spokesperson for the company said eligible patients with commercial insurance, including those with high deductible health plans or whose insurers don’t cover it, can get Auvi-Q for free.
Those who pay cash at the pharmacy counter will be charged $360 for two auto-injectors.
Auvi-Q’s introduction into Walgreens retail pharmacy comes as the nation faces a shortage of EpiPens sparked by manufacturing delays. Drugstores across the U.S. have run short on supply, and families have been scrambling to find EpiPens during the back-to-school season.
More articles on supply chain:
Data accuracy, clinical integration & more: 3 takeaways from AHRMM’s Supply Chain Conference
Kaiser changes EpiPen prescription policy after complaints
A drug to treat hemophilia, Non-Hodgkin lymphoma & more: 4 latest FDA approvals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
